Elanco Animal Health Inc (ELAT) Business Metric Overview - Stocknear

Elanco Animal Health Inc

NYSE: ELAT · Real-Time Price · USD
21.32
0.22 (1.04%)
At close: Jan 31, 2023, 10:00 PM

Elanco Animal Health Inc Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Cattle Revenue 268M 272M 754M 253M 249M 242M 210M 248M 469M 227M 248M 17M 15M 21M 27M 19M 64.1M 16.1M
Cattle Revenue Growth -1.47% -63.93% +198.02% +1.61% +2.89% +15.24% -15.32% -47.12% +106.61% -8.47% +1358.82% +13.33% -28.57% -22.22% +42.11% -70.36% +298.14% n/a
Contract Manufacturing Revenue 15M 12M 32M 14M 9M 12M 12M 9M 30M 12M 12M 569M 604M 583M 567M 578M n/a n/a
Contract Manufacturing Revenue Growth +25.00% -62.50% +128.57% +55.56% -25.00% 0.00% +33.33% -70.00% +150.00% 0.00% -97.89% -5.79% +3.60% +2.82% -1.90% n/a n/a n/a
Farm Animal Revenue 583M 546M 1.72B 530M 610M 561M 527M 573M 1.12B 545M 553M 639M 494M 527M 685M 645M n/a n/a
Farm Animal Revenue Growth +6.78% -68.26% +224.53% -13.11% +8.73% +6.45% -8.03% -48.88% +105.69% -1.45% -13.46% +29.35% -6.26% -23.07% +6.20% n/a n/a n/a
Pet Health Revenue 643M 635M 1.66B 486M 416M 495M 518M 675M 1.05B 471M 612M n/a n/a n/a n/a n/a n/a n/a
Pet Health Revenue Growth +1.26% -61.68% +240.95% +16.83% -15.96% -4.44% -23.26% -36.02% +123.99% -23.04% n/a n/a n/a n/a n/a n/a n/a n/a
Poultry Revenue 215M 189M 608M 188M 220M 184M 178M 183M 366M 176M 174M n/a n/a n/a n/a n/a n/a n/a
Poultry Revenue Growth +13.76% -68.91% +223.40% -14.55% +19.57% +3.37% -2.73% -50.00% +107.95% +1.15% n/a n/a n/a n/a n/a n/a n/a n/a
Swine Revenue 100M 85M 278M 88M 98M 93M 89M 102M 200M 95M 89M n/a n/a n/a n/a n/a n/a n/a
Swine Revenue Growth +17.65% -69.42% +215.91% -10.20% +5.38% +4.49% -12.75% -49.00% +110.53% +6.74% n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Non-Us Revenue 648M 639M 1.86B 543M 574M 589M 557M 714M 1.25B 553M 638M 703M 610M 624M 698M 709M 633.6M 468.1M 338.2M 357.8M 383.1M 386.6M 347.2M 1.2B 378.9M
Non-Us Revenue Growth +1.41% -65.65% +242.54% -5.40% -2.55% +5.75% -21.99% -43.11% +126.94% -13.32% -9.25% +15.25% -2.24% -10.60% -1.55% +11.90% +35.36% +38.41% -5.48% -6.60% -0.91% +11.35% -71.18% +217.95% n/a
United States Revenue 593M 554M 1.55B 487M 461M 479M 500M 543M 951M 475M 539M 522M 503M 507M 581M 533M 506.1M 421.5M 248.1M 299.9M 388.2M 395M 383.9M 1.1B 382.2M
United States Revenue Growth +7.04% -64.23% +218.07% +5.64% -3.76% -4.20% -7.92% -42.90% +100.21% -11.87% +3.26% +3.78% -0.79% -12.74% +9.01% +5.32% +20.07% +69.89% -17.27% -22.75% -1.72% +2.89% -65.13% +188.07% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017
Selling, General, and Administrative Revenue 400M 341M 321M 323M 313M 353M 327M 303M 298M 343M 320M 329M 342M 385M 348M 985.1M 277.7M 211.8M 233.6M 237.3M 243M 250.2M 230.1M 235.2M 227.7M 240.5M 229.2M 257M 246.3M
Selling, General, and Administrative Revenue Growth +17.30% +6.23% -0.62% +3.19% -11.33% +7.95% +7.92% +1.68% -13.12% +7.19% -2.74% -3.80% -11.17% +10.63% -64.67% +254.74% +31.11% -9.33% -1.56% -2.35% -2.88% +8.74% -2.17% +3.29% -5.32% +4.93% -10.82% +4.34% n/a
Research and Development Revenue 92M 94M 96M 87M 86M 81M 81M 80M 78M 82M 81M 92M 94M 94M 89M 112.7M 88.1M 59.4M 66.8M 67.3M 69.9M 68.8M 64.1M 61.1M 58.9M 61.4M 65.2M 62M 61.9M
Research and Development Revenue Growth -2.13% -2.08% +10.34% +1.16% +6.17% 0.00% +1.25% +2.56% -4.88% +1.23% -11.96% -2.13% 0.00% +5.62% -21.03% +27.92% +48.32% -11.08% -0.74% -3.72% +1.60% +7.33% +4.91% +3.74% -4.07% -5.83% +5.16% +0.16% n/a